End-stage kidney disease patients in the intensive care unit.

2. Shojaati K, Causevic M, Kadereit B et al. Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int 2004; 66: 2322–2328 3. Escher G, Mohaupt M. Role of aldosterone availability in preeclampsia. Mol Aspects Med 2007; 28: 245–544 4. Farese S, Shojaati K, Kadereit B et al. Blood pressure reduction in pregnancy by sodium chloride. Nephrol Dial Transplant 2006; 21: 1984–1987 5. Lindheimer MD, Conrad KC, Karumanchi SA. Renal physiology and disease in pregnancy. In: RJ Alpern, SC Hebert (eds). Seldin and Giebisch’s The Kidney: Physiology and Pathophysiology, 4th edn. San Diego: Academic Press, 2008, 2339– 2398 6. Luft FC, Gallery EDM, Lindheimer MD. Normal and abnormal volume homeostasis. In: MD Lindheimer, JM Roberts, FG Cunningham (eds). Chesley’s Hypertensive Disorders in Pregnancy, 3rd edn. San Diego: Elsevier, 2009 7. Lindheimer MD, Katz AI, Fluid and electrolyte metabolism in normal and abnormal pregnancy, In: AI Arieff, RA DeFronzo (eds). Fluid Electrolyte and Acid Base Disorders. New York: Churchill Livingstone, 1985, 1041–1086 8. Brown MA, Gallery EDM. Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications. Baillieres Clin Obstet Gynecol 1994; 8: 287–310 9. August P, Lenz T, Ales KL et al. Longitudinal study of the renin– angiotensin–aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990; 163: 1612–1621 10. Zeeman GG, Cunningham FG, Pritchard JA. The magnitude of the hemoconcentration in preeclampsia. Hypertens Preg in press 11. Gallery EDM, Hunyor SN, Gyory AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (preeclampsia) and chronic hypertension in pregnancy. Q J Med 1979; 48: 593–602 12. Robinson M. Salt in pregnancy. Lancet 1958; 1: 178–181 13. Casey ML, MacDonald PC. Metabolism of deoxycorticosterone and deoxycorticosterone sulfate in men and women. J Clin Invest 1982; 70: 312–319 14. MacDonald PC, Cutrer S, MacDonald SC et al. Regulation of extraadrenal steroid 21-hydroxylase activity. Increased conversion of plasma progesterone to deoxycorticosterone during estrogen treatment of women with a dead fetus. J Clin Invest 1982; 69: 469–478 15. Winkel CA, Milewich L, Parker CR Jr et al. Conversion of plasma progesterone to deoxycorticosterone in men, nonpregnant and pregnant women and adrenalectomized subjects. J Clin Invest 1980; 66: 803–812 16. Winkel CA, Simpson ER, MacDonald PC. Deoxycorticosterone biosynthesis in human kidney. Potential for formation of a potent mineralocorticoid in its site of action. Proc Nat Acad Sci USA 1980; 77: 7079–7083 17. Brown MA, Nicholson E, Ross MR et al. Progressive resetting of sodium–renin–aldosterone relationships in human pregnancy. Clin Exp Hypertens 1987; B5: 349–375 18. Brown MA, Zammit VC, Mitar DA et al. Renin–aldosterone relationships in pregnancy-induced hypertension. Am J Hypertens 1992; 5: 366–371 19. Merrill DC, Karoly M, Chen K et al. Angiotensin-(1–7) in normal and preeclamptic pregnancies. Endocrine 2002; 18: 239–245 20. Brosnihan KB, Neves LA, Anton L et al. Enhanced expression of Ang-(1–7) during pregnancy. Braz J Med Biol Res 2004; 37: 1255– 1262 21. Chen K, Merrill DC, Rose JC. The importance of angiotensin II subtype receptors for blood pressure control during mouse pregnancy. Reprod Sci 2007; 14: 694–704 22. Dechend R, Muller DN, Wallukut G et al. AT1 receptor agonistic antibodies, hypertension, and preeclampsia. Semin Nephrol 2004; 24: 571–579 23. Dechend R, Luft FC, Lindheimer MD. Agonistic autoantibodymediated disease. In: MD Lindheimer, JM Roberts, FG Cunningham (eds). Chesley’s Hypertensive Disorders in Pregnancy, 3rd edn. San Diego: Elsevier, 2009